BioCryst Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.4M | 849k | 7.59 |
| 2025-06-30 | $11M | 1.3M | 8.96 |
| 2025-03-31 | $7.8M | 1.0M | 7.50 |
| 2024-12-31 | $4.8M | 634k | 7.52 |
| 2024-09-30 | $5.2M | 682k | 7.60 |
| 2024-06-30 | $4.8M | 783k | 6.18 |
| 2024-03-31 | $3.7M | 719k | 5.08 |
| 2023-12-31 | $4.1M | 692k | 5.99 |
| 2023-09-30 | $3.8M | 543k | 7.08 |
| 2023-06-30 | $2.8M | 401k | 7.04 |
| 2023-03-31 | $2.9M | 348k | 8.34 |
| 2022-12-31 | $319k | 28k | 11.48 |
| 2022-03-31 | $1.5M | 92k | 16.26 |
| 2021-06-30 | $764k | 48k | 15.80 |
| 2020-03-31 | $1.2M | 612k | 2.00 |
| 2019-12-31 | $612k | 178k | 3.45 |
| 2018-03-31 | $78k | 16k | 4.80 |
| 2017-12-31 | $184k | 38k | 4.90 |
| 2017-09-30 | $256k | 49k | 5.24 |
| 2016-06-30 | $378k | 133k | 2.84 |
| 2016-03-31 | $570k | 202k | 2.83 |
| 2015-12-31 | $2.1M | 207k | 10.32 |
| 2015-09-30 | $2.7M | 238k | 11.40 |
| 2015-06-30 | $1.4M | 91k | 14.93 |
| 2015-03-31 | $1.5M | 161k | 9.03 |
| 2014-12-31 | $3.0M | 213k | 14.08 |
| 2014-09-30 | $1.9M | 169k | 10.93 |
| 2014-06-30 | $2.0M | 149k | 13.58 |
| 2014-03-31 | $6.2M | 528k | 11.68 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management